KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Neogenomics (NEO) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Neogenomics (NEO) over the last 15 years, with Q2 2023 value amounting to $127.1 million.

  • Neogenomics' Shares Outstanding rose 116.55% to $127.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $127.1 million, marking a year-over-year increase of 116.55%. This contributed to the annual value of $126.9 million for FY2022, which is 226.13% up from last year.
  • Neogenomics' Shares Outstanding amounted to $127.1 million in Q2 2023, which was up 116.55% from $127.2 million recorded in Q1 2023.
  • Neogenomics' Shares Outstanding's 5-year high stood at $127.2 million during Q1 2023, with a 5-year trough of $95.3 million in Q1 2019.
  • Its 5-year average for Shares Outstanding is $116.2 million, with a median of $119.9 million in 2021.
  • In the last 5 years, Neogenomics' Shares Outstanding skyrocketed by 2740.69% in 2019 and then skyrocketed by 116.55% in 2023.
  • Neogenomics' Shares Outstanding (Quarter) stood at $104.8 million in 2019, then increased by 6.96% to $112.1 million in 2020, then increased by 10.74% to $124.1 million in 2021, then rose by 2.26% to $126.9 million in 2022, then grew by 0.18% to $127.1 million in 2023.
  • Its Shares Outstanding stands at $127.1 million for Q2 2023, versus $127.2 million for Q1 2023 and $126.9 million for Q4 2022.